Colgate Passes Again On Offering Earnings Guidance Due To Market ‘Complexity, Volatility’
Colgate won’t provide full-year 2020 guidance even as the company reports 5.5% organic growth in the second quarter. Its sales in North America grew 24% on pandemic-related purchasing and price increases.
You may also be interested in...
Prestige Consumer Healthcare says pandemic-caused sales slump for many of its OTC drug products was offset somewhat by strong sales of brands including Dentek, Monistat and Summer’s Eve, which were boosted by targeted advertising and promotions.
C&D said sales of its brands including vitafusion, L’il Critters and PB8 supplements, Arm & Hammer, Aim and Close-Up toothpastes and Waterpick and Spinbrush power toothbrushes helped drive 8.8% growth to $386.4m for the personal and health care categories.
Macro factors that could hamper results include the economic recession caused by businesses’ reactions to novel coronavirus pandemic, the impact of COVID-19 on consumer buying trends and disruptions to supply chains.